A polymorphism in the angiogenesis inhibitor, endostatin, in lung cancer susceptibility

被引：10
|
作者：
Zambon, Lair [1 ]
Honma, Helen N. [1 ]
Lourenco, Gustavo J. [2 ]
Saad, Ivete A. B. [1 ]
Mussi, Ricardo K. [1 ]
Lima, Carmen S. P. [2 ]
机构：
[1] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Pulm Unit, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Clin Oncol Serv, Campinas, SP, Brazil
来源：
LUNG CANCER | 2008年 / 59卷 / 02期
关键词：
lung cancer; endostatin; D104N polymorphism; susceptibility;
D O I：
10.1016/j.lungcan.2007.10.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：276 / 278
页数：3
相关论文
共 50 条
  • [41] Angiogenesis and lung cancer
    Perol, Maurice
    Arpin, Dominique
    BULLETIN DU CANCER, 2007, 94 : S220 - S231
  • [42] Angiogenesis in lung cancer
    Chambers, JS
    ANNALS OF THORACIC SURGERY, 1998, 66 (06): : 2162 - 2162
  • [43] Effect of NF-κB inhibitor PDTC on VEGF and endostatin expression of mice with Lewis lung cancer
    Ping Gao
    Ya-Jie Gao
    Hong-Lu Liang
    Asian Pacific Journal of Tropical Medicine, 2015, (03) : 220 - 224
  • [44] Endostatin derivative angiogenesis inhibitors
    Zheng Meng-Jie
    CHINESE MEDICAL JOURNAL, 2009, 122 (16) : 1947 - 1951
  • [45] Effect of NF-κB inhibitor PDTC on VEGF and endostatin expression of mice with Lewis lung cancer
    Gao, Ping
    Gao, Ya-Jie
    Liang, Hong-Lu
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2015, 8 (03) : 220 - 224
  • [46] Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model
    Tanabe, K.
    Maeshima, Y.
    Ichinose, K.
    Kitayama, H.
    Takazawa, Y.
    Hirokoshi, K.
    Kinomura, M.
    Sugiyama, H.
    Makino, H.
    KIDNEY INTERNATIONAL, 2007, 71 (03) : 227 - 238
  • [47] ENDOSTATIN PEPTIDE, AN INHIBITOR OF ANGIOGENESIS, AMELIORATES RENAL ALTERATIONS IN THE EARLY STAGE OF DIABETIC NEPHROPATHY
    Ichinose, Kunihiro
    Maeshima, Yohei
    Yamamoto, Yoshihiko
    Kitayama, Hiroyuki
    Takazawa, Yuki
    Hirokoshi, Kumiko
    Sugiyama, Hitoshi
    Yamasaki, Yasushi
    Makino, Hirofumi
    NEPHROLOGY, 2005, 10 : A30 - A30
  • [48] Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin
    Sasaki, T
    Larsson, H
    Kreuger, J
    Salmivirta, M
    Claesson-Welsh, L
    Lindahl, U
    Hohenester, E
    Timpl, R
    EMBO JOURNAL, 1999, 18 (22): : 6240 - 6248
  • [49] Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia
    Gora-Tybor, J
    Blonski, JZ
    Robak, T
    MEDIATORS OF INFLAMMATION, 2003, 12 (03) : 167 - 171
  • [50] ANGIOGENESIS INHIBITOR ENDOSTATIN PROTECTS MICE WITH SEPSIS FROM MULTIPLE ORGAN DYSFUNCTION SYNDROME
    Peng, Yue
    Gao, Min
    Jiang, Yu
    Wang, Kangkai
    Zhang, Huali
    Xiao, Zihui
    Ou, Hao
    Yang, Bingchang
    Yang, Mingshi
    Xiao, Xianzhong
    SHOCK, 2015, 44 (04): : 357 - 364
12345